Editorial: antigenic response to CT ‐P13 and infliximab originator in IBD shows similar epitope recognition—evidence from basic science supports safe switching to biosimilars

Alimentary Pharmacology&Therapeutics,Volume 48, Issue 5, Page 574-575, September 2018.

Source: Alimentary Pharmacology and Therapeutics - August 10, 2018 Category: Drugs & Pharmacology Authors: L. Pouillon , M. Allocca , L. Peyrin ‐Biroulet Source Type: research